---
date: "2021-04-10T00:00:00Z"
external_link: ""
image:
  focal_point: Smart
  preview_only: true
summary: Randomised, double-blinded, placebo-controlled, adaptive design trial of the efficacy of acipimox in patients with mitochondrial myopathy
tags:
- AIMM
- Ongoing-trial
title: AIMM
url_code: ""
url_pdf: ""
url_slides: ""
url_video: ""
---

AIMM is funded by a grant from the [MRC](https://mrc.ukri.org/) to CI [Grainne Gorman](https://www.ncl.ac.uk/medical-sciences/people/profile/grainnegorman.html) and team.

It is a single-centre trial, being run by [The Newcastle upon Tyne Hospitals NHS Foundation Trust](https://www.newcastle-hospitals.nhs.uk/) and [Newcastle University](https://www.ncl.ac.uk/).

You can find out more at [The Lily Foundation](https://www.thelilyfoundation.org.uk/lily-research/uk-trials-research-studies/aimm-acipimox-mitochondrial-myopathy-study/), from the study's registration on [ISCRTN](https://doi.org/10.1186/ISRCTN12895613), or on its [award page](https://gtr.ukri.org/projects?ref=MR%2FR006458%2F1#/).
